Can Google Trends analysis confirm the public's need for information about the rare association of facial nerve paralysis with COVID-19 or the COVID-19 vaccination? - 10/03/23
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Highlights |
• | Apart from few short peaks, facial nerve paralysis and Bell's palsy predominantly show no noticeably increased public interest or increased need for information due to the pandemic. |
• | Interest in facial nerve paralysis and Bell's palsy plays a more or less negligible role in the population's need for information during the COVID-19 pandemic compared to more common topics such as COVID-19 vaccine or long COVID. |
• | Google Trends is a useful tool to demonstrate the recent informational needs of the public. |
Abstract |
Facial nerve paralysis or Bell's palsy have been suggested as possible consequences of SARS-CoV-2 infections, as well as possible side effects of COVID-19 vaccinations. Google Trends data have been used to evaluate worldwide levels of public awareness for these topics for pre- and post-pandemic years. The results demonstrate a relatively low public interest in facial nerve paralysis in comparison to other more common COVID-19 related topics. Some peaks of interest in Bell's palsy can most likely be explained as triggered by the media. Therefore, Google Trends has shown public's relatively low awareness of this rare neurological phenomenon during the pandemic.
Il testo completo di questo articolo è disponibile in PDF.Keywords : COVID-19, SARS-CoV-2, Search engine data, Google Trends, Bell's palsy, Facial nerve paralysis, Ramsay–Hunt syndrome type 2
Mappa
Vol 179 - N° 3
P. 218-222 - marzo 2023 Ritorno al numero
Articolo precedente
- Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes
- H. Chaumont, F. Kaczorowski, A. San-Galli, P.P. Michel, B. Tressières, E. Roze, I. Quadrio, A. Lannuzel
- Serology results after COVID vaccine in multiple sclerosis patients treated with fingolimod
- A. Ciccone, G. Mathey, C. Prunis, M. Debouverie
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.